The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

In the era of artificial intelligence (AI), various trends have been observed that utilize AI in multiple sectors, having a ...

With over 1,100 subjects enrolled across 39 clinical study sites, the company is developing and validating the study.

Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic skin conditi ...

Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...

Korean researchers link indoor mold toxins to worsening atopic dermatitis in dogs Indoor air pollutants may contribute to the ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

The global prevalence of atopic dermatitis -- a chronic skin condition -- is expected to reach 42.42 million by 2033, ...

Corvus Pharmaceuticals' stock plummeted ~40% after Phase 1 data for soquelitinib in AD showed mixed results. See why I ...

The data demonstrated a favorable safety profile and efficacy profile, supporting the ongoing development of soquelitinib for ...

At the recent SEC meeting for dermatology and allergy held on 5th and 6th December 2024, the expert panel reviewed the ...